DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Izumi N, Takehara T, Chayama K. , et al.
Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.
Hepatol Int 2018;
12 (04) 356-367
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.